3 Penny Stocks Trading Higher This Week
Most traders will start with a list of penny stocks to watch before jumping into a trade. The simple reason behind it is that there are different strategies involving numerous attributes. Some traders look for fast-moving stocks to scalp while others take a longer-term approach. Whether you’re looking to day trade or even invest in penny stocks having a “menu” of choices helps clear out some of the noise.
Think about it, especially if you’re new to day trading, how many times do you get distracted by shiny objects? In the same breath, how many times do those shiny objects fail to continue moving higher? More times than not, simply jumping into a breakout move poses more risk than anything. Instead, traders will us a list of penny stocks and then decide if it’s time to buy or just wait a bit.
Of course, if you’re experienced, I’m preaching to the choir. You understand the risks involved and plan out your trades without jumping headfirst into something you don’t know much about or haven’t at least studied its trend. In many ways, day trading, while exciting, can be perfected into a means of consistent profitability. You just need to have a clear approach to your trades as well as a real strategy.
So how do you put together a list of penny stocks to watch? Are you looking for stocks under $5, in general or are you looking for something more specific? Do you need to see news from companies or is technical analysis enough? All good things to keep in mind and at the end of the day, it can help you decide which stocks to watch and which to avoid. This having been said, are any of these on your list of penny stocks right now?
Penny Stocks To Buy [or avoid]: BioLineRx Ltd.
Do you read our weekend reports? If you do then you likely became familiar with BioLineRx Ltd. (BLRX Stock Report) recently. The company was 4th on our list of biotech penny stocks to watch this week. As we highlighted, much of the recent excitement stems (no pun intended) from its current Phase 3 GENESIS study. This is of its motixafortide treatment for stem cell mobilization currently indicated in patients with multiple myeloma.
Why might BLRX stock be moving this week? In my opinion, it likely has to do with what was said a few weeks back. Specifically, Philip Serlin, CEO of BioLineRx said in a Q3 business update the company expects data released “in the coming weeks”. Specifically, progression-free survival & overall survival data from the triple combination arm of a Phase 2a COMBAT/KEYNOTE-202 study. This followed patients treated with motixafortide and KEYTRUDA®, together with chemotherapy. Keep in mind that the company reported positive overall response rate data last year on half of the patients. Now we wait to see if “the coming weeks” include the ones before the new year.
Penny Stocks To Buy [or avoid]: BioCardia Inc.
BioCardia Inc. (BCDA Stock Report) has been on an aggressive climb this month. Since the start of December, BCDA stock has jumped from around $2.37 to highs this week of $4.20. What has helped give things a boost was progress with the company’s bioteherapeutic delivery system, Helix. An article reported that its system demonstrated the best safety profile among clinical transendocardial catheter injection systems used for cardiac cell therapy delivery.
Fast-forward a few weeks to recently and the company has come out with more big news. BioCardia announced that it expects the data safety monitoring board’s verbal feedback will be by the end of December 15th. The feedback is on on interim data from BioCardia’s pivotal Phase 3 CardiAMP Heart Failure Trial that is currently enrolling nationwide. The Board is then expected to give written feedback approximately 24 hours later. BioCardia said plans to provide an announcement pre-market on December 17, 2020 summarizing the feedback and outlining the next resulting steps.
While this is still speculative at best, the market digested this news favorably and shares spiked Monday morning. In light of the recent volatility, it’s important to keep focused on the main topic which is feedback. What will be offered on the status of this data? In the mean time, momentum continues buildings and BCDA stock has found a place on this list of penny stocks to watch this week.
Penny Stocks To Buy [or avoid]: Seelos Therapeutics Inc.
Speaking of psychedelic stocks to watch, Seelos Therapeutics Inc. (SEEL Stock Report) remains one of the lesser know, major US exchange-listed stocks to watch. We introduced this idea a while ago as traders on Robinhood have limited access to this new phenomenon.
Back in June, the company announced its final data from Phase I of its study of intranasal racemic ketamine (SLS-002). The CEO and Chairman of Seelos, Raj Mehra said, “Today’s announcement marks the most significant event so far in Seelos’ brief history. It is heartening to see that all intranasal doses were judged to be generally safe and well-tolerated, and the resolution of dissociative side-effect among all doses by the one-hour timepoint for this group mean affords that this therapy is truly differentiated, which enables Seelos to evaluate SLS-002 in indications beyond ASIB, such as first line MDD.”
The company previously received feedback from the FDA supporting the design of a 16-day study for Acute Suicidal Ideation and Behavior in patients with Major Depressive Disorder (MDD). In light of this, SEEL stock has continued climbing this week after the company announced that it raised $10 million in gross proceeds from an investment made by The Lind Partners. CEO Raj Mehra, Ph.D. said, “This financial commitment from Lind enables us to continue to execute our plans of advancing Seelos’ key programs, including the acute suicidal ideation and behavior trial for SLS-002.”
In light of this, will traders begin finding SEEL among their list of stocks to watch?